Delivery Order SPE2DB20D9135-SPE2DB24FZW08

Award Date 11/22/23
Potential Completion Date 11/24/23
Potential Value $3.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $5,678.70 contract is for the supply of NUCALA 100 MG/ML AUTO-INJECTORML, a specialty pharmaceutical product. This award is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $3,785.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order was issued under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, which has a ceiling value of up to $499,999,999 and runs through December 31, 2025. The current delivery order is for the supply of NUCALA 100 MG/ML...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $11,357.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which runs through March 13, 2024, is for the supply of Nucala 100 mg/mL auto-injector medication. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $3,785.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of NUCALA 100 MG/ML AUTO-INJECTORML, a biologic medication, to support the recurring medical supply needs of military health facilities worldwide. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) that...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $7,571.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which is part of a larger $499,999,999 indefinite delivery contract (IDC) with DMS Pharmaceutical Group, is for the supply of Nucala 100 mg/mL auto-injectors to support the recurring medical supply needs of military health facilities worldwide. DMS...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $3,785.80 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, which has a completion date of March 21, 2024, is for the supply of NUCALA 100 MG/ML auto-injectors to support the medical needs of military personnel and their dependents. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB...
The U.S. Defense Logistics Agency (DLA) has awarded a Firm Fixed Price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $11,357.40, is for the delivery of NUCALA 100 MG/ML AUTO-INJECTORML. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, to provide a comprehensive range of pharmaceutical items...
The U.S. Defense Logistics Agency (DLA) awarded a $3,785.80 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The order is for the pharmaceutical product NUCALA 100 MG/ML AUTO-INJECTORML and has a completion date of June 28, 2024. This order is part of a larger DLA Medical Supply Chain indefinite delivery contract (IDC) valued up to $499,999,999, which allows the DLA to issue delivery orders for a wide range of...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,892.90 contract, with a completion date of April 16, 2024, is to provide the DLA's Medical Supply Chain division with 100 mg/mL Nucala auto-injectors. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued up to $499,999,999, that allows the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,892.90 contract is for the delivery of Nucala 100 mg/mL auto-injectors. This delivery order falls under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract with the DLA to provide a comprehensive range of pharmaceutical products and medical supplies to military healthcare facilities. The...
  • SPE2DB20D9135
    Indefinite Delivery Contract
  • SPE2DB20D9135-SPE2DB24FZW08
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $3,785.80 contract is for the supply of NUCALA 100 MG/ML AUTO-INJECTOR medical products. This order is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a wide range of pharmaceutical items to support the medical needs of the Department of Defense (DoD) healthcare facilities. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing both routine and specialized medications, biologics, and medical consumables to military health facilities worldwide. This contract award does not have a set-aside designation.

Generated 1/9/25, 9:27 AM